Impact of Removable Versus Fixed Implant-supported Prostheses in Oral Health Quality of Life for Edentulous Patients (FALBALA)

December 17, 2021 updated by: Assistance Publique - Hôpitaux de Paris

Impact of Implant-supported Removable Prosthesis Versus Fixed Prosthesis on Quality of Life in Edentulous Patients: a Multicenter Non-inferiority Cross-over Trial

Comparison between fixed and removable implant-retained complete prostheses previously showed that while patients appreciate the ergonomic cleaning of removable prostheses, they prefer the comfort and masticatory efficiency of fixed prostheses. New treatment strategies are emerging; the use of telescopic attachments now offers a prosthetic alternative for the treatment of edentulous teeth at a lower financial cost than fixed prostheses.

To answer this question, the study is constructed as a cross-over. 30 patients will use a removable telescopic prosthesis and then a fixed prosthesis, or vice versa, for a period of 6 months according to randomization. They will answer a quality of life questionnaire after each period and finally choose their favorite prosthesis. The null hypothesis is that removable telescopic implant prostheses will result in a quality of life comparable to that obtained with fixed implant-supported prostheses.

The primary objective of this study is to demonstrate the non-inferiority of removable versus fixed prostheses on quality of life after 6 months of use of each implant-supported prosthesis in edentulous maxillary or mandibular patients. The measurement of the evolution of the quality of life is analyzed using the GOHAI questionnaire after 6 months of use of each prosthesis.

The secondary objectives are to:

  • Determine the decisional parameters in the final choice of the prosthesis by the patient at the end of the study, with the Mc Gill Denture Satisfaction Instrument,
  • Compare the masticatory efficiency between the two dentures (duration, number of cycles and frequency of chewing of the carrot test food, with each denture after 6 months of use),
  • Compare the oral hygiene between the two prostheses (peri-implant plaque index, after 6 months for each prosthesis),
  • Compare the adjustments and repair required after the placement of each prosthesis and the chairside treatment time to achieve them,
  • Compare the complications and their frequency of occurrence with each type of prosthesis during the 6-month wearing period.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Edentulism is defined as the loss of all natural teeth and is an important public health issue globally for its high prevalence (exceeding 10% in adults aged ≥ 50 years) and associated disability Epidemiological studies show a decrease in the prevalence of total edentulism but an increase in the number of edentulous people in the world in general and in Western society in particular, linked to the increase in life expectancy. In Europe, the edentulism rate varies greatly from one country to another. According to the WHO, in the 65+ age group, the rate of total edentulism in 2000 was 60-70% in some European countries and still 15% in France.

Prosthetic rehabilitation is a factor of social inequalities in health insofar as this care is poorly covered or not covered by social organizations. The different treatment solutions must be examined in terms of the gain they represent in terms of quality of life compared to their cost.

The improvement of retention of a removable prosthesis with implants was demonstrated. The comparison between fixed and removable implant-retained prostheses previously showed that while patients appreciate the ergonomic cleaning of removable prostheses, they prefer the comfort and masticatory efficiency of fixed prostheses. New treatment strategies are emerging; the use of telescopic attachments now offers a prosthetic alternative for the treatment of edentulous teeth at a lower financial cost than fixed prostheses. This treatment option is not well known. There are no randomized controlled studies directly comparing these two therapies in terms of quality of life.

To answer this question, the study is constructed as a cross-over. 30 patients will use a removable telescopic prosthesis and then a fixed prosthesis, or vice versa, for a period of 6 months according to randomization. They will answer a quality of life questionnaire after each period and finally choose their favorite prosthesis. The null hypothesis is that removable telescopic implant prostheses will result in a quality of life comparable to that obtained with fixed implant-supported prostheses.

The primary objective of this study is to demonstrate the non-inferiority of removable versus fixed prostheses on quality of life after 6 months of use of each implant-supported prosthesis in edentulous maxillary or mandibular patients. The measurement of the evolution of the quality of life is analyzed using the GOHAI questionnaire after 6 months of use of each prosthesis, i.e. twice during the study.

The GOHAI is a specific oral quality of life scale, comprising 12 items scored from 1 to 5 divided into 3 subparts corresponding to the functions of speaking, eating, and swallowing, psychosocial aspects, and pain/discomfort. A score of 60 corresponds to an optimal quality of life.

The secondary objectives are to:

  • Determine the decisional parameters in the final choice of the prosthesis by the patient at the end of the study, with the Mc Gill Denture Satisfaction Instrument,
  • Compare the masticatory efficiency between the two dentures (duration, number of cycles and frequency of chewing of the carrot test food, with each denture after 6 months of use),
  • Compare the oral hygiene between the two prostheses (peri-implant plaque index, after 6 months for each prosthesis),
  • Compare the adjustments and repair required after the placement of each prosthesis and the chairside treatment time to achieve them,
  • Compare the complications and their frequency of occurrence with each type of prosthesis during the 6-month wearing period.

Experimental design All patients will receive four or six dental implants, four in the mandible or six in the maxilla, depending on the arch to be treated. After an osseointegration phase of 4 to 6 months, two implant prostheses will be made for each patient, one removable, the other fixed. All patients will receive specific training in oral and peri-implant hygiene. According to the randomization, during an initial period of 6 months, half of the patients will be using the removable prosthesis, the other half the fixed prosthesis. A 15-day washout will be performed. No residual effect are expected, but the assessment of the baseline quality of life require daily use of the conventional prosthesis (without implant). Then, during a second period of 6 months, the patients will be using the second prosthesis. At the end of the study, the patient will choose the prosthesis he prefers and justifies his choice in a specific questionnaire.

A measurement of quality of life (GOHAI questionnaire) will be carried out before treatment and after use of each type of prosthesis. At the 6-month appointment of each prosthesis, evaluations will be performed including a plaque index measurement and a masticatory efficiency test. The adjustments and repairs required during the time the prosthesis will be worn, as well as the time required to perform them, will be recorded. A follow-up of the complications that occurred on each type of prosthesis will be set up during the two prosthetic phases.

The analysis will be carried out in intention-to-treat and per-protocol analysis. The treatment effect will be estimated by the difference in the evolution of the GOHAI score between the period with a removable prosthesis and the period without a removable prosthesis and its 95% confidence interval. A sequence and carry over effect will be sought.

Study Type

Interventional

Enrollment (Anticipated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients ≥ 18 years of age;
  • Mandibular AND/OR maxillary edentulous patients, treated with satisfying conventional denture for a minimum of 3 months;
  • Bone volume compatible with the placement of implants of at least 9 mm in length;
  • Sufficient inter-arch space;
  • Free and informed consent;
  • Affiliated to the social security fund.

Exclusion Criteria:

  • Systemic pathologies contraindicating the placement of implants (unbalanced diabetes, biphosphonates);
  • Smoking patient > 10 cigarettes per day;
  • Class IV bone according to the Leckholm and Zarb classification.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Patients treated with fixed implant denture
Patients quality of life will be compared when using a removable implant denture and a fixed implant denture, in a cross-over design. Fixed denture is considered the standard protocol.
Patients will receive four or six dental implants, four in the mandible or six in the maxilla, depending on the arch to be treated. After an osseointegration phase of 4 to 6 months, two implant prostheses will be made for each patient, one removable, the other fixed. According to the randomization, during an initial period of 6 months, half of the patients will be using the removable prosthesis, the other half the fixed prosthesis. A 15-day washout will be performed. Then, during a second period of 6 months, the patients will be using the second prosthesis.
removable implant denture
Experimental: Patients treated with removable implant denture
Patients quality of life will be compared when using a removable implant denture and a fixed implant denture, in a cross-over design. Removable denture is considered the experimental protocol.
Patients will receive four or six dental implants, four in the mandible or six in the maxilla, depending on the arch to be treated. After an osseointegration phase of 4 to 6 months, two implant prostheses will be made for each patient, one removable, the other fixed. According to the randomization, during an initial period of 6 months, half of the patients will be using the removable prosthesis, the other half the fixed prosthesis. A 15-day washout will be performed. Then, during a second period of 6 months, the patients will be using the second prosthesis.
removable implant denture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the evolution of the quality of life using the GOHAI questionnaire
Time Frame: 6 months
Measurement of the evolution of the quality of life is analyzed using the GOHAI questionnaire
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scores of the Mc Gill Denture Satisfaction Instrument
Time Frame: 21 months
Scores of the Mc Gill Denture Satisfaction Instrument, for the final choice of prosthesis, at the end of the study.
21 months
Measurement of the duration of chewing of the carrot test food
Time Frame: 6 months
Measurement of the duration of chewing of the carrot test food at the swallowing threshold, after 6 months, for each prosthesis;
6 months
Measurement of the number of cycles of chewing of the carrot test food
Time Frame: 6 months
Measurement of the number of cycles and frequency of chewing of the carrot test food at the swallowing threshold, after 6 months, for each prosthesis;
6 months
Measurement of the frequency of chewing of the carrot test food
Time Frame: 6 months
Measurement of the frequency of chewing of the carrot test food at the swallowing threshold, after 6 months, for each prosthesis;
6 months
Peri-implant plaque index
Time Frame: 6 months
Peri-implant plaque index (measured by the Mombelli score), after 6 months for each prosthesis
6 months
Adjustments required after placement
Time Frame: 6 months
Adjustments required after placement, with each prosthesis (subprosthetic injuries, premature and occlusal interferences, retouching of the prosthetic intrados or extrados, adjustment of the retention force, modification of the prosthetic profile), during the 6-month wearing period for each prosthesis; The time of adjustment is measured from the moment the patient sits in the dental chair to the moment he/she leaves the chair, the unit is the quarter hour;
6 months
Complications
Time Frame: 6 months
Complications (screw fractures, prosthetic screw loosening, ceramic fracture, prosthetic base fracture, attachment loss, abutment screw loosening, implant loss), during the 6-month wearing period, for each prosthesis.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2022

Primary Completion (Anticipated)

April 1, 2024

Study Completion (Anticipated)

May 1, 2025

Study Registration Dates

First Submitted

December 6, 2021

First Submitted That Met QC Criteria

December 17, 2021

First Posted (Actual)

December 20, 2021

Study Record Updates

Last Update Posted (Actual)

December 20, 2021

Last Update Submitted That Met QC Criteria

December 17, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • APHP210087

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complete Edentulism

Clinical Trials on fixed implant denture

3
Subscribe